... and with sound optimism into 2021.
Merck’s Q4 figures fully confirmed our strong view on the share. All three divisions contributed to the development, according their respective strengths. Guidance and the higher dividend both support our thinking. Nevertheless, the pandemic will still have a negative impact here and there, if virus mutations invalidate the vaccination efforts. Consensus was met.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
As strong as expected...
... and with sound optimism into 2021.
Merck’s Q4 figures fully confirmed our strong view on the share. All three divisions contributed to the development, according their respective strengths. Guidance and the higher dividend both support our thinking. Nevertheless, the pandemic will still have a negative impact here and there, if virus mutations invalidate the vaccination efforts. Consensus was met.